Membrane morphogenesis in retinal rod outer segments: inhibition by tunicamycin.
Isolated Xenopus laevis retinas were incubated with 3H-labeled mannose or leucine in the presence or absence of tunicamycin (TM), a selective inhibitor of dolichyl phosphate-dependent protein glycosylation. At a TM concentration of 20 micrograms/ml, the incorporation of [3H]mannose and [3H]leucine into retinal macromolecules was inhibited by approximately 66 and 12-16%, respectively, relative to controls. Cellular uptake of the radiolabeled substrates was not inhibited at this TM concentration. Polyacrylamide gel electrophoresis revealed that TM had little effect on the incorporation of [3H]leucine into the proteins of whole retinas and that labeling of proteins (especially opsin) in isolated rod outer segment (ROS) membranes was negligible. The incorporation of [3H]mannose into proteins of whole retinas and ROS membranes was nearly abolished in the presence of TM. Autoradiograms of control retinas incubated with either [3H]mannose or [3H]leucine exhibited a discrete concentration of silver grains over ROS basal disc membranes. In TM-treated retinas, the extracellular space between rod inner and outer segments was dilated and filled with numerous heterogeneously size vesicles, which were labeled with [3H]leucine but not with [3H]mannose. ROS disc membranes per se were not labeled in the TM-treated retinas. Quantitative light microscopic autoradiography of retinas pulse-labeled with [3H]leucine showed no differences in labeling of rod cellular compartments in the presence or absence of TM as a function of increasing chase time. These results demonstrate that TM can block retinal protein glycosylation and normal disc membrane assembly under conditions where synthesis and intracellular transport of rod cell proteins (e.g., opsin) are not inhibited.
Fliesler
S J
SJ
Rayborn
M E
ME
Hollyfield
J G
JG
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D005110:Extracellular Space / Q000378:metabolism; D005136:Eye Proteins / Q000378:metabolism; D005944:Glucosamine / Q000031:analogs & derivatives*; D007425:Intracellular Membranes / Q000648:ultrastructure; D007700:Kinetics; D008565:Membrane Proteins / Q000378:metabolism; D009024:Morphogenesis / Q000187:drug effects; D010786:Photoreceptor Cells / Q000648:ultrastructure*; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D012243:Rhodopsin / Q000378:metabolism; D012374:Rod Cell Outer Segment / Q000378:metabolism / Q000648:ultrastructure*; D017299:Rod Opsins; D014415:Tunicamycin / Q000494:pharmacology*; D014982:Xenopus laevis
D005136:Eye Proteins; D008565:Membrane Proteins; D017299:Rod Opsins; D014415:Tunicamycin; D012243:Rhodopsin; D005944:Glucosamine